Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumorsAndrea M. Chambers(Purdue University West Lafayette), Sandro Matosevic(Purdue University West Lafayette)bioRxiv (Cold Spring Harbor Laboratory)October 5, 202110.1101/2021.10.05.463201Cited by 2SaveCiteExport RISWatch citationsRelated PaperssynNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy|Nature Communications|2024|39Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors|eLife|2022|33